FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068463 [Registered on: 06/06/2024] Trial Registered Prospectively
Last Modified On: 05/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Case Control Study 
Study Design  Other 
Public Title of Study   Study on Nutritional Status of Children with Cerebral Palsy in Varanasi and Clinical Observational Study on the Effect of Suvarnaprashana in Children with C P.  
Scientific Title of Study   A Cross – Sectional Study on Nutritional Status of Children with Cerebral Palsy in Varanasi and a Prospective Clinical Observational Study on the Effect of Suvarnaprashana in Children with C P.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nisha Pandey 
Designation  PhD Schollar 
Affiliation  Istitute of Medical Science BHU 
Address  Department of Kaumarbhritya Faculty of Ayurveda IMS BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  9839915100  
Fax    
Email  nishapandey1990@bhu.ac.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kalpana Patni 
Designation  Asst Professor 
Affiliation  Institute of Medical Science BHU 
Address  Department of Kaumarbhritya Faculty of Ayurveda IMS BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  9456140578  
Fax    
Email  kalpana.patni@bhu.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Kalpana Patni 
Designation  Asst Professor 
Affiliation  Institute of Medical Science BHU 
Address  Department of Kaumarbhritya Faculty of Ayurveda IMS BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  9456140578  
Fax    
Email  kalpana.patni@bhu.ac.in  
 
Source of Monetary or Material Support  
Sir Sundar Lal Hospital, Institute of Medical Science, Banaras Hindu University Varanasi 221005, Uttar Pradesh, India  
 
Primary Sponsor  
Name  Institute of Medical Science BHU Varanasi 
Address  Dept of Kaumarbhritya/Balroga Faculty of Ayurveda Institute of Medical Science Banaras Hindu University Varanasi 221005,Uttar Pradesh, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kalpana Patni  Sir Sundar Lal Ayurvedic Hospital IMS BHU Varanasi   OPD NO 25,Dept of Kaumarbhritya/Balroga Faculty of Ayurveda IMS BHU Varanasi 221005
Varanasi
UTTAR PRADESH 
9456140578

kalpana.patni@bhu.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BanarasHinduUniversityInstituteofMedicalSciencesVaranasiIndia221005  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G809||Cerebral palsy, unspecified, (2) ICD-10 Condition:P919||Disturbance of cerebral status ofnewborn, unspecified. Ayurveda Condition: Children with Mastishk Pakshaaghaat(cerebral palsy) with devlopmental disabilities of both physical and mental,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  5.00 Day(s)
Gender  Both 
Details  1. Children diagnosed with CP
2. Age-1 year to 5 years of either sex.
3. Children with developmental disabilities of both physical and mental (Delayed
milestones). 
 
ExclusionCriteria 
Details   
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1.Assessment of nutritional status parameters including weight, height, BMI, and micronutrient levels.
2.Identification of prevalent nutritional deficiencies among children with cerebral palsy in Varanasi.
3.Evaluation of the impact of Suvarnaprashana on the developmental milestones of children with cerebral palsy.
4.Measurement of changes in motor function and cognitive abilities following Suvarnaprashana administration. 
8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
1.Exploration of dietary patterns and feeding difficulties among children with cerebral palsy.
2.Analysis of the correlation between nutritional status and severity of cerebral palsy symptoms.
3.Investigation of the safety profile of Suvarnaprashana in children with cerebral palsy.
4.Examination of potential improvements in quality of life indicators such as sleep patterns and mood. 
1 years 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
cross sectional study (n= 150) pre-diagnosed children of
Cerebral Palsy will be selected from OPD & IPD of department of Kaumarabhritya, Sir
Sunderlal Hospital, BHU, Varanasi District. Study includes children between 1 year to 5 years

For Observational Clinical study (n=60) also pre-diagnosed children of Cerebral Palsy will be
selected from OPD & IPD of department of Kaumarabhritya, Sir Sunderlal Hospital, BHU,
Varanasi District. Only those children with CP who will be prescribed Suvarnaprashana for
6 weeks along with Snehana (Ashwagandha bala tail)15 mint and Swedana (Shali Shashtika Pinda
Sweda) 15 mint will be assigned to intervention group 20 days and those who will be prescribed only Snehana
(Aswagandha bala tail) 15 mint and Swedana (Shali Shashtika Pinda Sweda) 15 mint will be assigned to
comparator group20 days. All registered patients will have received recommendation for
Suvarnaprashana and other procedures by their respective Consultant from department of
Kaumarbhritya/ Balroga, Faculty of Ayurveda IMS BHU after through clinical examination.
Parent/guardian of every selected patient will be explained about the procedure of
observation upon the child and thereby obtained his consent.Total duration of trial will be 2 months(8 weeks).

 
Close